Select a Region North America

M&A & BD&L Outlook and Perspectives on Commercial Due Diligence

Please join our M&A, BD&L and Commercial Due Diligence (CDD) leaders to discuss our current perspectives on the state of deal-making in the pharmaceutical and biotech sectors, and to discuss our point of view on the heightened importance of Commercial Due Diligence in the current market and how to optimize CDD efforts using best practices and risk mitigation techniques.

Thu, May 23, 20224
2:00 – 3:00 PM EDT

Webinar Presenters


James Stephanou

Partner, Strategy, M&A and Business Development

Faruk Abdullah

President, Professional Services and Chief Business Officer

Industry Co-Presenters

Jakub Pijewski, PhD
Vice President, US Commercial Strategy, Partnerships and BD&LGSK

Yao Zhang, PhD
Senior Director, Interventional Oncology, Johnson & Johnson Innovation